| 제품명 | Pioglitazone |
|---|---|
| CAS 번호 | 111025-46-8 |
| 분자식 | C19H20N2O3S |
| 분자량 | 356.44 |
| 외관 | 흰색에서 미백색의 결정성 분말 |
| 분석법 (HPLC) | ≥98% |
| 건조 손실 | ≤0.5% |
| 소각 잔류물 | ≤0.1% |
| 중금속 | ≤10 ppm |
| 융점 | 183-186°C |
| 특정 회전 | N/A (racemic) |
도움이 필요하신가요? 저희 팀에 문의해 주세요

동의어
Pioglitazone is a thiazolidinedione that has been a cornerstone in type 2 diabetes management for over two decades. It works by targeting PPAR-γ, a nuclear receptor that directly influences insulin sensitivity in adipose tissue, muscle, and liver. Unlike many other antidiabetic drugs that merely stimulate insulin release, pioglitazone addresses the root issue—insulin resistance—helping patients achieve better long-term glycemic control.
For manufacturers, pioglitazone remains a reliable, cost-effective API with a well-established safety profile. We supply pioglitazone as a high-purity crystalline powder, every batch shipped with a full COA, and we offer flexible packaging from 1 kg trial orders to bulk container shipments. Our global logistics network ensures timely delivery to any destination.
Room,5-0203, Courtyard 205, Lianhu District,Xi'an,Shaanxi,China